Install
Daily news and insights on the fast-growing longevity market – antiaging, biotech, research, investment, supplements and rejuvenation therapies. First Longevity Limited provides a service to strictly match groups or individuals seeking investment capital with individuals looking to invest. First Longevity Limited does
- 60articles · 30d
- 3+ day agolatest article
- Aug 15, 2026earliest in window
- 95%with images
- 332avg words
- Medical 51
- Health & Wellness 47
- Health 28
- Science & Technology 26
- Science & Nature 8
- Business & Industrial 7
- Economy, Business & Finance 5
- Beauty & Fitness 3
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Cumulus’ at-home EEG headset clears usability test in ALS
4+ day, 15+ hour ago (351+ words) The tool doctors have relied on for years to track ALS was built to measure grip strength and swallowing, not memory or mood. That gap is what Cumulus Neuroscience is trying to close, and its first real test of whether…...
New ALS drug data reveal a mitochondrial fix
5+ day, 16+ hour ago (522+ words) Longevity.Technology New ALS drug data reveal a mitochondrial fix Longevity.Technology is growing fast; we are open to conversations with prospective partners and investors who share our vision. Please get in touch if you are interested: NRG Therapeutics unpacks…...
Amprion expands Parkinson’s test to Europe
6+ day, 16+ hour ago (191+ words) Long before a patient ever shows a tremor, Parkinson’s disease may already be rewriting the biology of their brain. That gap, between when the disease actually starts and when doctors can currently detect it, is one of the biggest obstacles…...
New patent strengthens Alterity’s Parkinson’s investment
1+ week, 4+ day ago (247+ words) Patents rarely make headlines outside the biotech trade press, but for a clinical-stage company preparing to enter a pivotal trial, a strong patent estate can matter as much as the data itself. Alterity Therapeutics has just secured one of those…...
Greenstone bets on human cells to fix DMD hearts
1+ week, 6+ day ago (480+ words) Greenstone Biosciences, a Palo Alto biotech built around a biobank of more than 2,500 donor-derived induced pluripotent stem cell (iPSC) lines, has just received fresh federal backing to test whether skipping the animal step altogether can produce better drugs, faster [1]. The…...
AstronauTx turns sleep into new dementia target
2+ week, 2+ day ago (380+ words) Sleep has become one of the most talked-about levers in longevity science, credited with everything from metabolic health to cognitive resilience. AstronauTx, a UK biotech founded by SV Health’s Dementia Discovery Fund, is now translating that interest into a drug…...
Scientists create muscle that exercises itself
2+ week, 4+ day ago (418+ words) Researchers have engineered living muscle grafts that spontaneously contract beneath the skin and appear to reproduce some of exercise’s systemic effects, improving measures of muscle function, bone health and metabolism in aging mice [1]. “We have essentially captured the power of…...
Mount Sinai’s $1m XPRIZE bet: reset immune system, slow aging
2+ week, 5+ day ago (549+ words) Part of a ten-part series profiling each of the $101 million XPRIZE Healthspan competition’s Milestone 2 Awardees. Across the series, Longevity.Technology examines the science behind each team’s approach, the trial data supporting it and what stands between them and the competition’s…...
CND Life Sciences funding backs earlier Parkinson’s detection
2+ week, 5+ day ago (599+ words) One of the biggest frustrations in neurology is that by the time diseases such as Parkinson’s become obvious, they have often been quietly progressing for years. The tremors, stiffness and movement problems people associate with Parkinson’s are frequently the end…...
XellSmart scores FDA fast track for Parkinson’s cell therapy
3+ week, 3+ day ago (314+ words) For XellSmart, the decision builds on growing momentum. XS411 has already received permission to enter clinical trials in both China and the United States, while its Phase II registrational study in China has now completed patient enrollment. Parkinson’s affects more than…...